Page last updated: 2024-11-03

riluzole and Ventricular Dysfunction, Left

riluzole has been researched along with Ventricular Dysfunction, Left in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, S1
Benoist, D1
White, E1
Teng, W1
Saint, DA1

Other Studies

1 other study available for riluzole and Ventricular Dysfunction, Left

ArticleYear
Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current.
    British journal of pharmacology, 2010, Volume: 160, Issue:5

    Topics: Action Potentials; Animals; Calcium; Dose-Response Relationship, Drug; Electrocardiography; Heart; M

2010